Our company was founded with a mission to continually research and develop cutting-edge solutions and novel advancements in biotechnology to introduce the very best scientific approaches to oral health care.
Order now
Periodontal disease is a pathological inflammatory condition of the gum and bone support (periodontal tissues) surrounding the teeth.
One of the major concerns in the oral care industry continues to be the growing prevalence of periodontal disease. The Center for Disease Control estimates that some form of periodontal disease is prevalent in almost half of all adults age 30 and older.
Current research has also shown that periodontal disease has been linked to certain cancers, heart disease, lung disease, diabetes and other systemic pathologies.
In any stage of periodontal disease, a bacterial invasion of the periodontal tissues causes an overwhelming inflammatory response by the body. The body then releases potent toxins into the surrounding healthy tissues.
This results in a mass production of enzymes called Matrix Metalloproteinases (MMPs).
These harmful MMPs destroy and degrade healthy tissue and collagen, which leads to the recession of the gums and bone that surround the teeth.
Our goal is to inhibit or stop these MMPs from causing this damage to your oral tissues.
While researching the effects of the inflammatory response, we discovered that a certain combination of natural antioxidants inhibits the progression of these destructive enzymes (MMPs) and restores them to normal levels.
This proprietary and award-winning combination of antioxidants, called PolyLeaf™, is naturally derived from pomegranates, sumacs, and peony flowers.
Our mission is to incorporate our novel technology, PolyLeaf™, into a suite of oral care products that will not only target the bacterial insult in periodontal disease, but also the destructive enzymes (MMPs) produced in the body’s response, resulting in the most effective solution to oral disease and oral care on the market today.
Join us for exclusive discounts and our latest news.
